Literature DB >> 23508697

Design and semiparametric analysis of non-inferiority trials with active and placebo control for censored time-to-event data.

Karola Kombrink1, Axel Munk, Tim Friede.   

Abstract

The clinical trial design including a test treatment, an active control and a placebo is called the gold standard design. In this paper, we develop a statistical method for planning and evaluating non-inferiority trials with gold standard design for right-censored time-to-event data. We consider both lost to follow-up and administrative censoring. We present a semiparametric approach that only assumes the proportionality of the hazard functions. In particular, we develop an algorithm for calculating the minimal total sample size and its optimal allocation to treatment groups such that a desired power can be attained for a specific parameter constellation under the alternative. For the purpose of sample size calculation, we assume the endpoints to be Weibull distributed. By means of simulations, we investigate the actual type I error rate, power and the accuracy of the calculated sample sizes. Finally, we compare our procedure with a previously proposed procedure assuming exponentially distributed event times. To illustrate our method, we consider a double-blinded, randomized, active and placebo controlled trial in major depression.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Cox proportional hazards model; non-inferiority; retention of effect; sample size allocation; semiparametric; three-arm design

Mesh:

Year:  2013        PMID: 23508697     DOI: 10.1002/sim.5769

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  1 in total

1.  Group-sequential three-arm noninferiority clinical trial designs.

Authors:  Toshimitsu Ochiai; Toshimitsu Hamasaki; Scott R Evans; Koko Asakura; Yuko Ohno
Journal:  J Biopharm Stat       Date:  2016-02-18       Impact factor: 1.051

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.